查詢結果分析
來源資料
頁籤選單縮合
題名 | 運動禁藥--Stanozolol=Doping--Stanozolol |
---|---|
作者 | 何應志; 許美智; Ho, Ying-chi; Hsu, Mei-chich; |
期刊 | 國立體育學院論叢 |
出版日期 | 20011000 |
卷期 | 12:1 2001.10[民90.10] |
頁次 | 頁225-233 |
分類號 | 528.9013 |
語文 | chi |
關鍵詞 | 同化性類固醇; Stanozolol; Anabolic steroid; |
中文摘要 | Stanozolol是蛋白同化效力╱男性激素效力之比值相當高的同化性類固醇,而且可以促進膠原合成,以及影響許多血液因子,所以在皮膚醫學及血液、血管疾病的治療上受到相當的注目;同時它也被運動員拿來濫用,以期能增進肌力與運動表現。由於它多樣的藥效,使其副作用也多於一般同化性類固醇,而在進行藥物檢測時,因其特殊的結構以及較低的尿中排泄量,也使得Stanozolol較一般同化性類固醇難以檢測。 |
英文摘要 | Stanozolol is a synthetic anabolic steroid with high anabolic/androgenic ratio. It is used clinically in the treatment of osteoporosis, blood dieases, vascular disorders, and it is a novel therapeutic agent in dermatology. In addition to these medical uses, stanozolol is abused by athletes for muscle build-up and performance. It's side effects are more than other anabolic steroids. The structurally different to most anabolic steroids and its low excretion rate in urine make its detection difficult. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。